COVID-19 vaccine development from the perspective of cancer patients
Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patient...
Saved in:
Main Authors: | Yang He (Author), Yi Ding (Author), Bo Cao (Author), Yi Huang (Author), Xiao Wang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Considerations on the clinical development of COVID-19 vaccine from trial design perspectives
by: Zhiwei Jiang, et al.
Published: (2021) -
A Perspective on the Role of Point-of-Care "Immuno-Triaging" to Optimize COVID-19 Vaccination Distribution in a Time of Scarcity
by: Yi Zhang, et al.
Published: (2021) -
Management of pain in cancer patients- lessons from practices during the COVID-19: a qualitative study of cancer care providers' perspectives
by: Georgina Cornall, et al.
Published: (2024) -
Acceptability for COVID-19 vaccination: perspectives from Muslims
by: Li Ping Wong, et al.
Published: (2022) -
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak
by: Xinrui Wang, et al.
Published: (2024)